Indices closed UP.
S&P 500 @ 2662.84, high 2672.08, low 2649.58
RSI @ 48.15
CMF -0.155
Internals were :
UP volume led by 3.92 to 1 in NYSE & 2.00 to 1 in Nasdaq
Advancing stocks led by 2.75 to 1 in NYSE & 1.69 to 1 in Nasdaq
Net new 52 wk highs were leading by 25 in NYSE & 31 in Nasdaq
VIX Down 5.58% @ 18.94
Oil @ $63.54
Gold @ $1328.50
Stocks which were UP 1% or more included FSLR
HAL FB JD AMZN BAC CNQ AMD CSIQ FCX JKS
LEN LULU LVS MA V MRVL NFLX SPWR SU TECK
TSLA TWTR ALDR CHK TK RIG FEYE LNG GS MGA
FNSR MS MCD KORS TNA NKE KBH X M PANW CNX...
AH news....ACTG UP 5.63%, SSYS UP 3.7%
AH futures UP
AH Asian Markets Mixed
AH Oil & Gold UP
About market, TAPE worked its way higher again, there is some cautious buying in this oversold market. Internals were mostly positive except CMF. Most stocks were strong except select semiconductor stocks. Maintain your exposure and add IF comfort level is high. There is only a closing BLOG on Friday's around 7 PM.
BLOG does NOT give buy or sell.
Saleem
6 comments:
Hi Saleem,
Rebought OPTN @ 19.33
An analyst note today gave me more confidence to hold the stock:
Optinose launch of Xhance could far exceed expectations, says Jefferies
After surveying 50 high prescribing physicians, Jefferies analyst David Steinberg says Optinose's launch of Xhance could far exceed expectations. Physicians report 57% of their patients will receive prescriptions annually at peak, Steinberg tells investors in a research note. Using the most conservative response regarding patient use per year, implied peak sales could reach $1.1B, well above the $700M consensus, the analyst contends. He believes that while payer pushback is inevitable, the survey suggests Xhance "could be one of the top sector launches in some time." The anlayst keeps a Buy rating on Optinose shares with a $31 price target.
Stocktrader
Hi Saleem,
Sold EXAS @ 39.56
The stock didn't bounce as expected with the rebound in the general market. That tells me the stock is still weak. Since this was mostly a "trade", I'll let it go for now. Besides that, the technicals are pretty bad still.
Stocktrader
Hi Saleem,
Trimmed some BABA @ 170.68
Given the relative underperformance in this market rebound, it doesn't deserve the highest weighting in the portfolio.
Stocktrader
Hi Stocktrader,
Good luck with OPTN.
Saleem
Hi Saleem,
Bought KIDS @ 16.18 with my remaining cash.
The early innings of a great story. I'll see what develops here.
Stocktrader
Hi Stocktrader,
Good luck with KIDS
Saleem
Post a Comment